magnesium sulfate has been researched along with bay-k-8644 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Billman, GE | 1 |
Phillippe, M | 1 |
Fischer, JR; Fomin, VP; Gibbs, SG; Hurd, WW; Natarajan, V; Singh, DM | 1 |
Ding, B; Gao, F; Gao, X; Guo, H; Xu, H; Zhou, L | 1 |
4 other study(ies) available for magnesium sulfate and bay-k-8644
Article | Year |
---|---|
Effect of calcium channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Death, Sudden; Dogs; Hemodynamics; Magnesium Sulfate; Nifedipine; Ventricular Fibrillation; Verapamil | 1989 |
Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Signaling; Female; In Vitro Techniques; Ion Transport; Magnesium Sulfate; Models, Biological; Muscle, Smooth; Myometrium; Oxytocin; Rats; Rats, Sprague-Dawley; Uterine Contraction | 1998 |
Magnesium sulfate inhibits the oxytocin-induced production of inositol 1,4,5-trisphosphate in cultured human myometrial cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cell Culture Techniques; Cells, Cultured; Drug Interactions; Egtazic Acid; Female; Humans; Inositol 1,4,5-Trisphosphate; Magnesium Sulfate; Myometrium; Nifedipine; Oxytocin; Sodium Fluoride | 2002 |
Magnesium sulfate provides neuroprotection in lipopolysaccharide-activated primary microglia by inhibiting NF-κB pathway.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channels, L-Type; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Inflammation; Interleukin-1beta; Lipopolysaccharides; Magnesium Sulfate; Microglia; Models, Animal; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |